Estrogen and the female heart

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 31-39

  Knowlton, A A ^a,b   Korzick, D H ^c  

^a The Department of Veteran's Affairs Northern California VA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Cardioprotection; HRT; HSF1; HSP72; Mitochondria; TNF

Indexed keywords

CAVEOLIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; HEAT SHOCK PROTEIN; ESTROGEN RECEPTOR;

ACUTE CORONARY SYNDROME; AGING; BLOOD CLOTTING; CARDIOVASCULAR SYSTEM; CELL PROTECTION; CELLULAR DISTRIBUTION; CHRONIC DRUG ADMINISTRATION; DRUG MECHANISM; EARLY INTERVENTION; ESTROGEN ACTIVITY; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; AGE; ANIMAL; CLINICAL TRIAL (TOPIC); HEART; HEART MUSCLE; METABOLISM; PHYSIOLOGY;

AGE FACTORS; ANIMALS; CLINICAL TRIALS AS TOPIC; ESTROGENS; FEMALE; HEART; HUMANS; MYOCARDIUM; RECEPTORS, ESTROGEN;

EID: 84901500355     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2014.01.002     Document Type: Review

References (162)

1. Abete P., Calabrese C., Ferrara N., et al. Exercise training restores ischemic preconditioning in the aging heart. J. Am. Coll. Cardiol. 2000, 36(2):643-650.
2. Acconcia F., Ascenzi P., Bocedi A., et al. Palmitoylation-dependent estrogen receptor α membrane localization: regulation by 17β-estradiol. Mol. Biol. Cell 2005, 16:231-237.
3. Alexaki V.I., Charalampopoulos I., Kampa M., Nifli A.P., Hatzoglou A., Gravanis A., Castanas E. Activation of membrane estrogen receptors induce pro-survival kinases. J. Steroid Biochem. Mol. Biol. 2006, 98:97-110.
4. Arnstein P.M., Buselli E.F., Rankin S.H. Women and heart attacks: prevention, diagnosis and care. Nurse Pract. 1996, 21:57-58.
5. Bagot C.N., Marsh M.S., Whitehead M., et al. The effect of estrone on thrombin generation may explain the different thrombotic risk between oral and transdermal hormone replacement therapy. J. Thromb. Haemost. 2010, 8:1736-1744.
6. Barrett-Connor E. Sex differences in coronary heart disease: why are women so superior? The 1995 ancel keys lecture. Circulation 1997, 95(1):252-264.
7. Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am. J. Epidemiol. 2007, 166:506-510.
8. Batenburg W.W., Jansen P.M., van den Bogaerdt A.J., Danser J. Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase. Cardiovasc. Res. 2012, 94(1):136-143.
9. Bell J.R., Bernasochi G.B., Varma U., Raaijmakers A.J.A., Delbridge L.M.D. Sex and sex hormones in cardiac stress: mechanistic insights. J. Steroid Biochem. Mol. Biol. 2013, 137:124-135.
10. Boonyaratanakornkit V. Scaffolding proteins mediating membrane-initiated extra-nuclear actions of estrogen receptor. Steroids 2011, 76:877-884.
11. Booth E.A., Lucchesi B.R. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovasc. Toxicol. 2008, 8:101-113.
12. Booth E.A., Obeid N.R., Lucchesi B.R. Activation of estrogen receptor-{alpha} protects the in vivo rabbit heart from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2005, 289(5):H2039-H2047.
13. Bopassa J.C., Eghbali M., Toro L., Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition port opening and protects the heart against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2010, 298:H16-H23.
14. Brailoiu G.C., Benamar K., Arterburn J.B., et al. Aldosterone increases cardiac vagal tone via G protein-coupled oestrogen receptor activation. J. Physiol. 2013, 591(17):4223-4235.
15. Bryzgalova G., Gao H., Ahren B., et al. Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006, 49(3):588-597.
16. Burns P.G., Krukenkamp I.B., Caldarone C.A., Kirvaitis R.J., Gaudette G.R., Levitsky S. Is the preconditioning response conserved in senescent myocardium?. Ann. Thoracic Surg. 1996, 61(3):925-929.
17. Camper-Kirby D., Welch S., Walker A., et al. Myocardial Akt activation and gender: increased nuclear activity in females versus males. Circ. Res. 2001, 88(10):1020-1027.
18. Canonico M., Fournier A., Caracaillon L., et al. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from E3N Cohort Study. Arterioscler. Thromb. Vasc. Biol. 2010, 30:340-345.
19. Chambliss K.L., Yuhanna I.S., Mineo C., et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res. 2000, 87(11). 44e-452.
20. Chen D., Washbrook E., Sarwar N., et al. Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 2002, 21:4921-4931.
21. Cheskis B.J., Greger J.G., Nagpal S., Freedman L.P. Signaling by estrogens. J. Cell. Physiol. 2007, 213(3):610-617.
22. Chimenti C., Kajstura J., Torella D., et al. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ. Res. 2003, 93(7):604-613.
23. Chu B., Soncin F., Price B.D., Stevenson M.A., Calderwood S.K. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1. J. Biol. Chem. 1996, 271(48):30847-30857.
24. Cochran R., Gwinup G. Coronary artery disease in young females: possibility of oophorectomy as an etiologic agent. Arch. Intern. Med. 1962, 110(2):162-165.
25. Colditz G.A., Willett W.C., Stampfer M.J., Rosner B., Speizer F.E., Hennekens C.H. Menopause and the risk of coronary heart disease in women. N. Engl. J. Med. 1987, 316(18):1105-1110.
26. Craig E.E., Hood D.A. Influence of aging on protein import into cardiac mitochondria. Am. J. Physiol. Heart Circ. Physiol. 1997, 272(6):H2983-H2988.
27. Dai D.F., Rabinovitch P.S., Ungvari Z. Mitochondria and cardiovascular aging. Circ. Res. 2012, 110(8):1109-1124.
28. Dan P., Cheung J.C.Y., Scriven D.R.L., Moore E.D.W. Epitope-dependent localization of estrogen receptorα, but not-β in en fase arterial endothelium. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1295-H1306.
29. Dawn B., Bolli R. Increasing evidence that estrogen is an important modulator of bone marrow mediated cardiac repair after acute infarction. Circulation 2006, 114(21):2203-2205.
30. Delbeck M., Golz S., Vonk R., et al. Impaired left-ventricular cardiac function in male GPR30-deficient mice. Mol. Med. Rep. 2011, 4(1):37-40.
31. Demirel H.A., Hamilton K.L., Shanely R.A., Tumer N., Koroly M.J., Powers S.K. Age and attenuation of exercise-induced myocardial HSP72 accumulation. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H1609-H1615.
32. Deng N., Zhang J., Zong C., et al. Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol. Cell. Proteomics 2011, 10(2).
33. Deroo B.J., Korach K.S. Estrogen receptors and human disease. J. Clin. Invest. 2006, 116(3):561-570.
34. Deschamps A.M., Murphy E. Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1806-H1813.
35. Deschamps A.M., Murphy E., Sun J. Estrogen receptor activation and cardioprotection in ischemia reperfusion injury. Trends Cardiovasc. Med. 2010, 20(3):73-78.
36. Dessy C., Feron O., Balligand J.L. The regulation of endothelial nitric oxide synthase by caveolin: a paradigm validated in vivo and share by the 'endothelium-derived hyperpolarizing factor'. Pflugers Arch. Eur. J. Physiol. 2010, 459:817-827.
37. Driggers P.H., Segars J.H. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrin. Met. 2002, 13:422-427.
38. Du X.J., Dart A.M., Riemersma R.A., Oliver M.F. Sex difference in presynaptic adrenergic inhibition of norepinephrine release during normoxia and ischemia in the rat heart. Circ. Res. 1991, 68(3):827-835.
39. Du X.J., Riemersma R.A., Dart A.M. Cardiovascular protection by oestrogen is partly mediated through modulation of autonomic nervous function. Cardiovasc. Res. 1995, 30(2):161-165.
40. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66:295-306.
41. Dutta D., Calvani R., Bernabei R., Leeuwenburgh C., Marzetti E. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ. Res. 2012, 110(8):1125-1138.
42. Falkeborn, M., Schairer, C., Naessén, T., Persson, I., 2000. Risk of myocardial infarction after oophorectomy and hysterectomy. J. Clin. Epidemiol. 53, 832-837.
43. Farsetti A., Grasselli A., Bacchetti S., Gaetano C., Capogrossi MC. The telomerase tale in vascular aging: Regulation by estrogens and nitric oxide signaling. J. Appl. Physiol. 2008, 91360.
44. Faus H., Haendler B. Post-translational modifications of steroid receptors. Biomed. Pharmacother. 2006, 60(9):520-528.
45. Feldman R.D., Gros R. Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. Br. J. Pharmacol. 2011, 163(6):1163-1169.
46. Fenton R.A., Dickson E.W., Meyer T.E., Dobson J.G. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J. Mol. Cell. Cardiol. 2000, 32(7):1371-1375.
47. Fenton R.A., Dickson E.W., Dobson J. Inhibition of phosphatase activity enhances preconditioning and limits cell death in the ischemic/reperfused aged rat heart. Life Sci. 2005, 77(26):3375-3388.
48. Figtree G.A., McDonald D., Watkins H., Channon K.M. Truncated estrogen receptor alpha 46-kDa isoform in human endothelial cells: relationship to acute activation of nitric oxide synthase. Circulation 2003, 107(1):120-126.
49. Fleming I. Molecular mechanisms underlying the activation of eNOS. Pflugers Arch. Eur. J. Physiol. 2010, 459:793-806.
50. Forster C., Kietz S., Hultenby K., Warner M., Gustafsson J.A. Characterization of the ERbeta -/- mouse heart. Proc. Nat. Acad. Sci. U.S.A. 2004, 101(39):14234-14239.
51. Fu M., Wang C., Zhang X., Pestell R.G. Acetylation of nuclear receptors in cellular growth and apoptosis. Biochem. Pharmacol. 2004, 68(6):1199-1208.
52. Gabel S.A., Walker V.R., London R.E., Steenbergen C., Korach K.S., Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 2005, 38(2):289-297.
53. Grady D., Herrington D., Bittner V., et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/Progestin Replacement study follow-up (HERS II). JAMA 2002, 288:49-57.
54. Grodstein F., Clarkson T., Manson J.E. Understanding the divergent data on postmenopausal hormone therapy. N. Engl. J. Med. 2003, 348(7):645-650.
55. Grodstein F., Manson J.E., Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J. Women's Health 2006, 15(1):35-44.
56. Gros R., Ding Q., Liu B., Chorazyczewski J., Feldman R.D. Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am. J. Physiol. Cell Physiol. 2013, 304(6):C532-C540.
57. Hamada H., Kim M.K., Iwakura A., et al. Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation 2006, 114(21):2261-2270.
58. Hamilton K.L., Gupta S., Knowlton A.A. Estrogen and regulation of heat shock protein expression in female cardiomyocytes: cross-talk with NF6B signaling. J. Mol. Cell. Cardiol. 2004, 36(4):579-586.
59. Hamilton K.L., Mbai F.N., Gupta S., Knowlton A.A. Estrogen, heat shock proteins, and NF{kappa}B in human vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 2004, 24(9):1628-1633.
60. Hansford R.G. Lipid oxidation by heart mitochondria from young adult and senescent rats. Biochem. J. 1978, 170:285-295.
61. Harman S.M., Brinton E.A., Cedars M., et al. KEEPS: the Kronos early estrogen prevention study. Climacteric 2005, 8(1):3-12.
62. Haynes M.P., Li L., Sinha D., et al. Src kinase mediates phosphatidylinositol 3-Kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen. J. Biol. Chem. 2003, 278(4):2118-2123.
63. Hayward C.S., Kelly R.P., Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc. Res. 2000, 46(1):28-49.
64. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-α knockout mice. PNAS 2000, 97(23):12729-12734.
65. Heydari A.R., You S., Takahashi R., Gutsmann-Conrad A., Sarger K.D., Richardson A. Age-related alterations in the activation of heat shock transcription factor 1 in rat hepatocytes. Exp. Cell Res. 2000, 256:83-93.
66. Hulley S., Grady D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998, 280:605-613.
67. Hunter J.C., Kostyak J.C., Novotny J.L., Simpson A.M., Korzick D.H. Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKC{delta}, PKC{epsilon}, Akt, and GSK3beta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 292(2):R800-R809.
68. Isoyama S., Nitta-Komatsubara Y. Acute and chronic adaptation to hemodynamic overload and ischemia in the aged heart. Heart Fail. Rev. 2002, 7:63-69.
69. Jankowski M., Rachelska G., Donghao W., McCann S.M., Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11765-11770.
70. Juhaszova M., Rabuel C., Zorov D.B., Lakatta E.G., Sollott S.J. Protection in the aged heart: preventing the heart-break of old age?. Cardiovasc. Res. 2005, 66(2):233-244.
71. Kajstura J., Cheng W., Sarangarajan R., et al. Necrotic and apoptotic myocyte cell death in aging fischer 344 rats. Am. J. Physiol. 1996, 271:H1215-H1228.
72. Kam K.W.L., Qi J.S., Chen M., Wong T.M. Estrogen reduces cardiac injury and expression of {beta}1-adrenoceptor upon ischemic insult in the rat heart. J. Pharmacol. Exp. Ther. 2004, 309(1):8-15.
73. Kang L., Zhang X., Xie Y., et al. Involvement of estrogen receptor variant ER-α36, not GPR30, in nongenomic signaling. Mol. Endocrinol. 2010, 24:709-721.
74. Kawasaki T., Chaudry I.H. The effects of estrogen on various organs: therapeutic approach for sepsis, trauma, and reperfusion injury. Part 1: central nervous system, lung and heart. J. Anesth. 2012, 26:883-891.
75. Keung W., Chan M.L.Y., Ho E.Y.W., Vanhoutte P.M., Man R.Y.K. Non-genomic activation of adenylyl cyclase and protein kinase G by 17β-estradiol in vascular smooth muscle of the rat superior mesenteric artery. Pharmacol. Res. 2011, 64:509-516.
76. Kim K.H., Bender J.R. Membrane-initiated actions of estrogen on the endothelium. Mol. Cell. Endocrinol. 2009, 308(1-2):3-8.
77. Knowlton A.A., Lee A.R. Estrogen and the cardiovascular system. Pharmacol. Ther. 2012, 135(1):54-70.
78. Knowlton A.A., Sun L. Heat shock factor-1, steroid hormones, and regulation of heat shock protein expression in the heart. Am. J. Physiol. 2001, 280:H455-H464.
79. Korzick D., Lancaster T. Age-related differences in cardiac ischemia-reperfusion injury: effects of estrogen deficiency. Pflugers Arch. Eur. J. Physiol. 2013, 465(5):669-685.
80. Kuiper G.G.J.M., Carlsson B., Grandien K., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 1997, 138(3):863-870.
81. Lakatta E.G., Sollott S.J. Perspectives on mammalian cardiovascular aging: humans to molecules. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2002, 132(4):699-721.
82. Lancaster T.S., Jefferson S.J., Korzick D.H. Local delivery of a PKCε-activating peptide limits ischemia reperfusion injury in the aged female rat heart. Am. J. Physiol. Regul. Integ. Comp. Physiol. 2011, 301(5):R1242-R1249.
83. Lancaster T.S., Jefferson S.J., Hunter J.C., et al. Quantitative proteomic analysis reveals novel mitochondrial targets of estrogen deficiency in the aged female rat heart. Physiol. Genomics 2012, 44(20):957-969.
84. Levin E.R. Plasma membrane estrogen receptors. Trends Endocrinol. Metab. 2010, 20(10):477-482.
85. Li L., Haynes M.P., Bender J.R. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. PNAS 2003, 100(8):4807-4812.
86. Liao W.X., Magness R.R., Chen D. Expression of estrogen receptors-α and -β in the pregnant ovine uterine artery. Biol. Reprod. 2005, 72:530-537.
87. Lindsey S.H., Carver K.A., Prossnitz E.R., Chappell M.C. Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2. Lewis female rat. J. Cardiovasc. Pharmacol. 2011, 57:598-603.
88. Liu P., Xu B., Cavalieri T.A., Hock C.E. Age-related difference in myocardial function and inflammation in a rat model of myocardial ischemia-reperfusion. Cardiovasc. Res. 2002, 56(3):443-453.
89. Locke M. Heat shock transcription factor activation and hsp72 accumulation in aged skeletal muscle. Cell Stress Chaperones 2000, 5:45-51.
90. Locke M., Tanguay R.M. Diminished heat shock response in the aged myocardium. Cell Stress Chaperones 1996, 1:251-260.
91. Marber M.S., Mestril R., Chi S.H., Sayen M.R., Yellon D.M., Dillmann W.H. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J. Clin. Invest. 1995, 95:1854-1860.
92. Mariani, J., Ou, R., Bailey, M., et al., 2000. Tolerance to ischemia and hypoxia is reduced in aged human myocardium. 120th ed., pp. 660-667.
93. McDonald T.G., Van Eyk J.E. Mitochondrial proteomics: undercover in the lipid bilayer. Basic Res. Cardiol. 2003, 98:219-227.
94. Meldrum D.R. Estrogen increases protective proteins following trauma and hemorrhage. Am. J. Physiol. Regul. Integ. Comp. Physiol. 2006, 290(3):R809-R811.
95. Mendez P., Garcia-Segura L.M. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells. Endocrinology 2006, 147(6):3027-3039.
96. Meyer M.R., Field A.S., Kanagy N.L., Barton M., Prossnitz E.R. GPER regulates endothelin-dependent vascular tone and intracellular calcium. Life Sci. 2012, 91(13-14):623-627.
97. Miller V., Kaplan J., Schork N., et al. Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol. Sex Diff. 2011, 2(1):14.
98. Mineo C., Shaul P.W. Circulating cardiovascular disease risk factors and signaling in endothelial cell caveolae. Cardiovasc. Res. 2006, 70(1):31-41.
99. Murphy E. Estrogen signaling and cardiovascular disease. Circ. Res. 2011, 109(6):687-696.
100. Murphy E., Steenbergen C. Preconditioning: the mitochondrial connection. Annu. Rev. Physiol. 2007, 69(1):51-67.
101. Nakamura Y., Suzuki T., Miki Y., et al. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Mol. Cell. Endocrinol. 2004, 219:17-26.
102. Nakano M., Mann D.L., Knowlton A.A. Blocking the endogenous increase in HSP72 increases susceptibility to hypoxia and reoxygenation in isolated adult feline cardiocytes. Circulation 1997, 95(6):1523-1531.
103. Nikolic I., Liu D., Bell J.A., Collins J., Steenbergen C., Murphy E. Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J. Mol. Cell. Cardiol. 2007, 42(4):769-780.
104. Novotny J.L., Simpson A.M., Tomicek N.J., Lancaster T.S., Korzick D.H. Rapid estrogen receptor-{alpha} activation improves ischemic tolerance in aged female rats through a novel protein kinase C{epsilon}-dependent mechanism. Endocrinology 2009, 150(2):889-896.
105. Olié, V., Canonico, M., Scarabin, P.Y., 2011. Postmenopausal hormone therapy and venous thromboembolism. Thrombosis Res. 127 Supplement 3, S26-S29.
106. Patel V.H., Chen J., Ramanjaney A., et al. G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress. Int. J. Mol. Med. 2010, 26:193-199.
107. Pechenino A.S., Lin L., Mbai F.N., et al. Impact of aging vs. estrogen loss on cardiac gene expression: late estrogen replacement and inflammation. Physiol. Genomics 2011, 43:1065-1073.
108. Pelzer, T., Arias Loza, P.A., Hu, K., et al., 2005. Increased mortality and aggravation of heart failure in estrogen receptor-{beta} knockout mice after myocardial infarction. Circulation 01.
109. Pepe S. Dysfunctional ischemic preconditioning mechanisms in aging. Cardiovasc. Res. 2001, 49(1):11-14.
110. 2+ activation of PDH. Am. J. Physiol. Heart Circ. Physiol. 1999, 276(1):H149-H158.
111. *. Am. J. Hypertens. 2005, 18(11):1388-1395.
112. Phillips G.B. Is atherosclerotic cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox. J. Clin. Endocrinol. Metab. 2005, 90(5):2708-2711.
113. Podlutsky A., Ballabh P., Csiszar A. Oxidative stress and endothelial dysfunction in pulmonary arteries of aged rats. Am. J. Physiol. Heart Circ. Physiol. 2010, 298(2):H346-H351.
114. Razani B., Engelman J.A., Wang X.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 2001, 276(41):38121-38138.
115. Recchia A.G., De Francesco E.M., Vivacqua A., et al. The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1 (HIF-1) in breast cancer cells and cardiomyocytes. J. Biol. Chem. 2011, 286(12):10773-10782.
116. Revankar CM., Cimino D.F., Sklar LA., Arterburn JB., Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 1106943.
117. Roach R.E.J., Lijfering W.M., Helmerhorst F.M., Cannegieter S.C., Rosendaal F.R., Van Hylckama Vlieg A. The risk of venous thrombosis in women over 50-years old using oral contraception or postmenopausal hormone therapy. J. Thrombosis Haemostasis 2013, 11(1):124-131.
118. Robertson T., Kennard E.D., Mehta S., et al. Influence of gender on in-hospital clinical and angiographic outcomes and on one-year follow-up in the New Approaches to Coronary Intervention (NACI) registry. Am. J. Cardiol. 1997, 80:26K-39K.
119. Rosenberg L., Hennekens C.H., Rosner B., Belanger C., Rothman K.J., Speizer F.E. Early menopause and the risk of myocardial infarction. Am. J. Obstet. Gynecol. 1981, 139:47-51.
120. Ross J.L., Howlett S.E. Age and ovariectomy abolish beneficial effects of female sex on rat ventricular myocytes exposed to simulated ischemia and reperfusion. PLoS One 2012, 7(6):e38425.
121. Saeedi R., Wambolt R., Parsons H., et al. Gender and post-ischemic recovery of hypertrophied rat hearts. BMC Cardiovasc. Disord. 2006, 6(1):8.
122. Saunders P.T., Maguire S.M., Gaughan J., Millar M.R. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J. Endocrinol. 1997, 154(3):R13-R16.
123. Schulman D., Latchman D.S., Yellon D.M. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(4):H1630-H1636.
124. Schwend T., Gustafsson J. False positives in MALDI-TOF detection of ERβ in mitochondria. Biochem. Biophys. Res. Commun. 2006, 343(3):707-711.
125. Shih C.D. Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J. Biomed. Sci. 2009, 16(1):60.
126. Smith N.L., Heckbert S.R., Lemaitre R.N., et al. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 2006, 26(12):2807-2812.
127. Smith, N.L., Heckbert, S.R., Lemaitre, R.N., Reiner, A.P., Lumley, T., Rosendaal, F.R., Psaty, B.M., 2013. Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens. JAMA Internal Med.
128. Song X., Li G., Vaage J., Valen G. Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischemia-reperfusion injury in mice. Acta Physiol. Scand. 2003, 177(4):459-466.
129. Stevenson J.C., Hodis H., Pickar J.H., Lobo R.A. Coronary heart disease and menopause management: the swinging pendulum of HRT. Atherosclerosis 2009, 207:336-340.
130. Stice J.P., Knowlton A.A. Estrogen, NFκB and the heat shock response. Mol. Med. 2008, 14(7-8):517-527.
131. Stice J.P., Chen L., Kim S.C., et al. 17β-Estradiol, aging, inflammation and the stress response in the female heart. Endocrinology 2011, 152:1589-1598.
132. Stice J.P., Mbai F.N., Chen L., Knowlton A.A. Rapid activation of nuclear factor-κB by 17β-estradiol and selective estrogen receptor modulators: pathways mediating cellular protection. Shock 2012, 38(2):128-136.
133. Suzuki K., Murtuza B., Sammut I.A., Latif N., Jayakumar J., Smolenski R.T., Kaneda Y., Sawa Y., Matsuda H., Yacoub M.H., et al. Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation 2002, 106(90121). 270I-276.
134. Takahashi K., Ohmichi M., Yoshida M., et al. Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells. J. Endocrinol. 2003, 178:319-329.
135. Tani M., Honma Y., Hasegawa H., Tamaki K. Direct activation of mitochondrial KATP channels mimics preconditioning but protein kinase C activation is less effective in middle-aged rat hearts. Cardiovasc. Res. 2001, 49(1):56-68.
136. Tchaikovski S.N., Rosing J. Mechanisms of estrogen-induced venous thromboembolism. Thromb. Res. 2010, 126:5-11.
137. Tomicek N.J., Miller-Lee J.L., Hunter J.C., Korzick D.H. Estrogen receptor beta does not influence ischemic tolerance in the aged female rat heart. Cardiovasc. Ther. 2013, 31(1):32-37.
138. Too CKL., Giles A., Wilkinson M. Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts. Mol. Cell. Endocrinol. 1999, 150:161-167.
139. Trost S.U., Omens J.H., Karlon W.J., et al. Protection against myocardial dysfunction after a brief ischemic period in transgenic mice expressing inducible heat shock protein 70. J. Clin. Invest. 1998, 101(4):855-862.
140. Urata Y., Ihara Y., Murata H., et al. 17β-Estradiol protects against oxidative stress-induced cell death through the glutathione/glutaredoxin-dependent redox regulation of Akt in myocardiac H9c2 cells. J. Biol. Chem. 2006, 281(19):13092-13102.
141. Villablanca A., Lubahn D., Shelby L., Lloyd K., Barthold S. Susceptibility to early atherosclerosis in male mice is mediated by estrogen receptor {alpha}. Arterioscler. Thromb. Vasc. Biol. 2004, 24(6):1055-1061.
142. Voss M.R., Stallone J.N., Li M., Cornelussen R.N.M., Knuefermann P., Knowlton A.A. Gender differences in the expression of heat shock proteins: the effect of estrogen. Am. J. Physiol. Heart Circ. Physiol. 2003, 285:H687-H692.
143. Wang M., Crisostomo P., Wairiuko G.M., Meldrum D.R. Estrogen receptor-α mediates acute myocardial protection in females. Am. J. Physiol. Heart Circ. Physiol. 2006, 290(6):H2204-H2209.
144. Wang M., Tsai B.M., Reiger K.M., Brown J.W., Meldrum D.R. 17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. J. Mol. Cell. Cardiol. 2006, 40(2):205-212.
145. Wang M., Crisostomo P.R., Markel T., Wang Y., Lillemoe K.D., Meldrum D.R. Estrogen receptor beta mediates acute myocardial protection following ischemia. Surgery 2008, 144(2):233-238.
146. Wang M., Wang Y., Weil B., et al. Estrogen receptor β mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2009, 296:R972-R978.
147. Wang H., Jessup J.A., Lin M.S., Chagas C., Lindsey S.H., Groban L. Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodeling in oophorectomized mRen2. Lewis rats. Cardiovasc. Res. 2012, 94(1):96-104.
148. Watanabe T., Akishita M., Nakaoka T., et al. Estrogen receptor β mediates the inhibitory effect of estradiol on vascular smooth muscle cells proliferation. Cardiovac. Res. 2003, 59:734-744.
149. Wenger N.K., Shaw L.J., Vaccarino V. Coronary heart disease in women: update 2008. Clin. Pharmacol. Ther. 2007, 83(1):37-51.
150. Willems L., Zatta A., Holmgren K., Ashton K.J., Headrick J.P. Age-related changes in ischemic tolerance in male and female mouse hearts. J. Mol. Cell. Cardiol. 2005, 38(2):245-256.
151. Writing Group for the Women's Health Initiative Investigators, 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. JAMA 288(3), 321-333.
152. Wu Q., Chambliss K.L., Umetani M., Mineo C., Shaul P.W. Non-nuclear estrogen receptor signaling in the endothelium. J. Biol. Chem. 2011, 286(17):14737-14743.
153. Wuest J.H., Dry T.J., Edwards J.E. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation 1953, 7(6):801-809.
154. Xing D., Nozell S., Chen Y.F., Hage F., Oparil S. Estrogen and mechanisms of vascular protection. Arterioscler. Thromb. Vasc. Biol. 2009, 29(3):289-295.
155. Xu Y., Arenas I.A., Armstrong S.J., Davidge S.T. Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc. Res. 2003, 57(2):388-394.
156. Yang S.H., Liu R., Perez E.J., et al. Mitchondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4130-4135.
157. Yu W., Dahl G., Werner R. The connexin43 gene is responsive to oestrogen. Proc. R. Soc. Lond. B Biol. Sci. 1994, 255(1343):125-132.
158. Yu X., Handong M., Barman S.A., et al. Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle. Am. J. Physiol. Endocrinol. Metab. 2011, 301:E882-E888.
159. Zhai P., Eurell T.E., Cotthaus R., Jeffery E.H., Bahr J.M., Gross D.R. Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats. Am. J. Physiol. 2000, 279:H2766-H2775.
160. Zhai P., Eurell T.E., Cotthaus R.P., Jeffery E.H., Bahr J.M., Gross D.R. Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts. Am. J. Physiol. Heart Circ. Physiol. 2001, 281(3):H1223-H1232.
161. Zhang D., Trudeau V.L. Integration of membrane and nuclear estrogen receptor signaling. Comp. Biochem. Physiol. A: Mol. Integr. Physiol. 2006, 144(3):306-315.
162. Zhao X., Eghbali-Webb M. Gender-related differences in basal and hypoxia-induced activation of signal transduction pathways controlling cell cycle progression and apoptosis, in cardiac fibroblasts. Endocrine 2002, 18(2):137-145.